We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.
- Authors
Kim, Seok Jin; Kim, Kihyun; Kim, Byung Soo; Jo, Deog-Yeon; Kang, Hye Jin; Kim, Jin Seok; Mun, Yeung-Chul; Kim, Chul Soo; Sohn, Sang Kyun; Eom, Hyeon-Seok; Kwak, Jae-Yong; Shim, Hyeok; Yoon, Hwi-Joong; Jin, Jong-Youl; Min, Chang-Ki; Shin, Hyunchoon; Won, Jong-Ho; Lee, Je-Jung; Kwon, Jung Hye; Joo, Young-Don
- Abstract
Aim: The Korean Multiple Myeloma Working Party performed a nationwide registration of multiple myeloma patients via a web-based data bank system. Methods: We retrospectively analyzed registered data from 3,209 patients since 1999. Results: The median overall survival (OS) was 50.13 months (95% confidence interval: 46.20–54.06 months). Patients ≤40 years demonstrated a longer OS than patients >65 years of age (median OS 71.13 vs. 36.73 months, p < 0.001). Patients who received novel agents at any time during their treatments showed a longer OS than patients who did not (median OS 42.23 vs. 55.50 months, p < 0.001). Response to treatment was associated with OS, with tandem autologous stem cell transplantation (SCT) producing longer OS than single autologous SCT. Conclusions: We demonstrated associations between survival outcomes and treatment modalities as well as baseline disease characteristics in a registry of multiple myeloma patients using a web-based data analysis. Copyright © 2009 S. Karger AG, Basel
- Subjects
SOUTH Korea; MULTIPLE myeloma; B cell lymphoma; MONOCLONAL gammopathies; PLASMACYTOMA; PATIENTS
- Publication
Acta Haematologica, 2009, Vol 122, Issue 4, p200
- ISSN
0001-5792
- Publication type
Article
- DOI
10.1159/000253027